top of page

Summit Agenda

08:00-08:45

Registration and Welcome Coffee

08:45-09:00

Welcome and Introduction

Marc Sultan (Chair)
Vijay Tiwari (Co-Chair)

Session I:
Recent advances in Genomics and its impact on translational medicine

09:00-09:05

Opening and Introduction to Session

Clare Balendran

(Novo Nordisk)

09:05-09:20

Applications of genomics to early clinical development planning in translational medicine

Mike Mendelson

(Novartis)

09:20-09:35

Identification of likely causal, modifiable traits related to cardiomyopathies and heart failure to de-risk drug development

Alix Berton

(Bayer)

09:35-09:50

Single-cell RNA sequencing reveals monocyte-derived alveolar macrophages as key drivers of smoke-induced lung inflammation and tissue remodelling

Christian Wohnhaas

(Boehringer Ingelheim)

09:50-10:05

Democratizing data-driven medicine through decentralized NGS data analytics

Philippe Menu

(Sophia Genetics)

10:05-10:35

Panel Discussion and Q&A

Panel: Clare Balendran, Mike Mendelson, Alix Berton, Christian Wohnhaas, Philippe Menu

10:35-11:05

Coffee Break & Poster Session

Session II:
Future-enabling Genomics Technologies in Drug Development and Precision Medicine 

11:05-11:10

Opening and Introduction to Session

Priscila Teixeira

(Roche)

11:10-11:25

Exploring the Potential: Applications of Genomics Technologies in Early Development at pRED

Marc Sultan

(Roche)

11:25-11:40

Enabling decentralized clinical trial initiatives with novel precision medicine genomic technologies

Holly Soares

(Pfizer)

11:40-11:55

Use of single-cell RNAseq and deconvolution approaches to characterize transcriptional signatures of fibrosis and inflammation in NASH liver biopsies

Michael Burczynski

(Regeneron)

11:55-12:10

Enabling Precision Medicine by Combining Multi-Omics Analysis and Artificial Intelligence

Corinne Solier

(Scailyte)

12:10-12:25

Genomic strategies in forward and reverse translation

Gitte Neubauer

(GSK)

12:25-12:55

Panel Discussion and Q&A

Panel: Priscila Teixeira, Marc Sultan, Holly Soares, Michael Burczynski, Corinne Solier, Gitte Neubauer

12:55-14:15

Lunch Break & Poster Session

14:15-14:30

Event Partner Presentation: 10xGenomics

Accelerate your drug discovery and development with single cell and spatial profiling

Sara Milosevic

(10x Genomics)

14:30-14:45

Event Partner Presentation: Illumina

Unlock the GenomiX Potential for Biomarker Discovery

Benton Davies & Samuel Kroll (Illumina)

14:45-15:00

Event Partner Presentation: Mission Bio

Pinpoint Disease-driving Clones to Deliver a More Targeted Therapy: Single-cell Multi-Omics & the MRD Horizon

​

​

Matthew H. Cato
(Mission Bio)

Session III:
Collaborative Ecosystems in Genomics-driven Precision Medicine

15:00-15:05

Opening and Introduction to Session

Vijay Tiwari

15:05-15:20

Liquid Biopsy: From Discovery to Clinical Implementation

Klaus Pantel

(University Medical Center Hamburg-Eppendorf)

15:20-15:35

Unlocking the power of Tumor Fraction Analysis in liquid Comprehensive Genomic profiling testing

Julian Jungmann
(Foundation Medicine)

15:35-15:50

Mapping the human body: translational applications of Human Cell Atlas

Rasa Elmentaite

(Wellcome Sanger Institute)

15:50-16:20

Coffee Break & Poster Session

16:20-16:25

Introduction to Session

Marc Sultan
 

16:25-16:40

Genomics England Multimodal Cancer Research Platform

Prabhu Arumugam

(Genomics England)

16:40-16:55

AstraZeneca’s Genomics Initiative: Transforming drug discovery and development through genomics

Dirk Paul

(AstraZeneca)

16:55-17:40

Panel Discussion and Q&A:
Learning from each other: how to foster a collaborative Ecosystems in Genomics-driven Precision Medicine?

Panel: Marc Sultan, Holly Soares, Julian Jungmann, Rasa Elmentaite, Prabhu Arumugam​​​​, Dirk Paul

17:40-17:50

Closing Remarks and Takeaways

Marc Sultan (Chair)
Vijay Tiwari (Co-Chair)

17:50-19:00

Networking Apéro

19:00-21:00

Dinner at Restaurant Chez Jeannot (not included in delegate fee, ticket reservation required)

bottom of page